Approval · Notice of Compliance 10100 · 2009
ALFAXAN: Notice of Compliance 10100
Issued March 18, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10100
- Date
- March 18, 2009
- Company
- Jurox Pty LimitedRutherford, New South Wales, Australia
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Gabaa receptor blocker
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALFAXAN | 02324040 | Cancelled Post Market |
Medicinal ingredients
- ALFAXALONE 10 MG per ML